Impax Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$3.85M Sell
31,751
-134,757
-81% -$16.8M 0.23% 113
2018
Q1
$21.3M Buy
166,508
+621
+0.4% +$83.9K 1.23% 23
2017
Q4
$23.2M Buy
165,887
+1,944
+1% +$271K 1.33% 19
2017
Q3
$21.3M Buy
163,943
+1,600
+1% +$212K 1.22% 26
2017
Q2
$21.5M Buy
162,343
+1,564
+1% +$200K 1.21% 25
2017
Q1
$20M Buy
160,779
+1,102
+0.7% +$132K 1.12% 27
2016
Q4
$18.4M Sell
159,677
-148,205
-48% -$17.1M 1.05% 32
2016
Q3
$36.4M Buy
307,882
+1,203
+0.4% +$146K 2.08% 4
2016
Q2
$37.2M Buy
306,679
+415
+0.1% +$47.2K 2.16% 2
2016
Q1
$33.1M Buy
306,264
+21,753
+8% +$2.25M 1.77% 4
2015
Q4
$29.2M Buy
+284,511
New +$28.6M 1.62% 9

Other funds holding JNJ

Impax Asset Management's JNJ Position: Q2 2018 in Review

Impax Asset Management reduced its Johnson & Johnson (JNJ) stake by 81% in Q2 2018, selling an estimated $16.8M and leaving 31,751 shares worth $3.85M. The position accounts for 0.23% of the portfolio, ranked #113.

Impax Asset Management first reported a position in JNJ in Q4 2015 and has held it in 11 quarters since. The position peaked at $37.2M in Q2 2016. 2,593 funds tracked by Wall St. Rank hold JNJ as of Q2 2018.

  • Impax Asset Management held 31,751 shares of Johnson & Johnson worth $3.85M as of Q2 2018.
  • Impax Asset Management sold 134,757 Johnson & Johnson shares in Q2 2018, an estimated $16.8M.
  • Johnson & Johnson made up 0.23% of Impax Asset Management's portfolio in Q2 2018, its #113 holding.
  • Impax Asset Management first reported a position in Johnson & Johnson in Q4 2015 and has held it in 11 quarters since.
  • Impax Asset Management's Johnson & Johnson position peaked at $37.2M in Q2 2016.
  • 2,593 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2018.

Based on Impax Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.